Evaluation and Treatment Strategy Development of Coronary Heart Disease Guided by OCT Based on Multimodal Deep Learning
NCT ID: NCT06544681
Last Updated: 2024-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
2000 participants
OBSERVATIONAL
2024-08-20
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
OCT-based Machine Learning FFR for Predicting Post-PCI FFR
NCT06341361
Impact of OCT on Outcomes in AMI
NCT05266547
Comparisons of Morphological Measurement Between Coronary Computed Tomography and Optical Coherence Tomography
NCT03021382
High-risk Features of Coronary Lesions in CTA and OCT
NCT06089343
Does Co-registration of OCT and Angiography Reduce Geographic Miss of Stent Implantation?
NCT02671123
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Coronary Stent Malapposition
Measurement results of deep learning-based OCT system: Coronary Stent Malapposition
Coronary stenting with planned drug eluting stent (DES).
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. A deep learning-based OCT system was used to measure the adherence of coronary stents.
Coronary Stent Well Apposed
Measurement results of a deep learning-based OCT system: Coronary Stent Well Apposed
Coronary stenting with planned drug eluting stent (DES).
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. A deep learning-based OCT system was used to measure the adherence of coronary stents.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Coronary stenting with planned drug eluting stent (DES).
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. A deep learning-based OCT system was used to measure the adherence of coronary stents.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Angiography was performed, and OCT imaging of criminal blood vessels was performed before intervention;
* Type of coronary heart disease: Unstable angina pectoris (UA), ST elevation myocardial infarction (STEMI) And non-ST elevation myocardial infarction (NSTEMI);
Exclusion Criteria
* Failure to complete follow-up;
* Previous coronary artery bypass grafting;
* Severe liver or kidney insufficiency;
* Infectious diseases, malignancies and bleeding diseases;
* OCT image quality was caused by large thrombus volume or residual blood in lumen and percutaneous coronary angiography Poor and further excluded.
20 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shihezi University
OTHER
Xiang Ma
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiang Ma
professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pengfei Liu, M.D
Role: PRINCIPAL_INVESTIGATOR
First Affiliated Hospital of Xinjiang Medical University
Xinliang Peng, M.D
Role: PRINCIPAL_INVESTIGATOR
First Affiliated Hospital of Xinjiang Medical University
Abudusalamu Tuerdimaimaiti, M.D
Role: PRINCIPAL_INVESTIGATOR
First Affiliated Hospital of Xinjiang Medical University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022B03022-3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.